Page last updated: 2024-08-17

fluocinolone acetonide and Acute Disease

fluocinolone acetonide has been researched along with Acute Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Aazami, H; Acosta, AM; Ansley, JF; Chu, L; De Valle, O; Dennis, P; Ehmer, D; Hedrick, JA1
Ansley, J; Butehorn, HF; Byers, J; Douglis, F; Esterhuizen, K; Hernández, FJ; Hussain, I; Ismail, K; Lanier, B; Lansford, B; Pumarola, F; Spektor, Z1
Rodrigo, C; Rodrigo, GJ1
Klasner, AK; Nakanishi, AK; Rubin, BK1
McFadden, ER1
Rodrigo, C; Rodrigo, G1
Eichenberger-de-Beer, H1

Trials

6 trial(s) available for fluocinolone acetonide and Acute Disease

ArticleYear
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone Acetonide Among Patients With Acute Otitis Externa: A Randomized Clinical Trial.
    JAMA network open, 2022, 07-01, Volume: 5, Issue:7

    Topics: Acute Disease; Administration, Topical; Adult; Anti-Bacterial Agents; Ciprofloxacin; Earache; Female; Fluocinolone Acetonide; Humans; Otitis Externa

2022
Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
    JAMA otolaryngology-- head & neck surgery, 2017, 04-01, Volume: 143, Issue:4

    Topics: Acute Disease; Administration, Topical; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Humans; Infant; Male; Middle Ear Ventilation; Otitis Media; Treatment Outcome

2017
Triple inhaled drug protocol for the treatment of acute severe asthma.
    Chest, 2003, Volume: 123, Issue:6

    Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Forced Expiratory Volume; Humans; Ipratropium; Male; Prospective Studies; Steroids, Fluorinated

2003
A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children.
    Chest, 2003, Volume: 124, Issue:3

    Topics: Acute Disease; Administration, Inhalation; Administration, Oral; Adolescent; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child; Female; Fluocinolone Acetonide; Humans; Lung Volume Measurements; Male; Oxygen; Prednisone; Treatment Outcome

2003
Inhaled flunisolide for acute severe asthma.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:3 Pt 1

    Topics: Acute Disease; Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Analysis of Variance; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Chi-Square Distribution; Double-Blind Method; Drug Administration Schedule; Emergencies; Female; Fluocinolone Acetonide; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoids; Heart Rate; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Placebos

1998
[Therapeutic experiences with a new topical corticoid (Fluocinonid FAPG)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1972, Nov-21, Volume: 61, Issue:47

    Topics: Acetates; Acute Disease; Chronic Disease; Clinical Trials as Topic; Eczema; Evaluation Studies as Topic; Fluocinolone Acetonide; Humans; Lichen Planus; Neurodermatitis; Ointments; Psoriasis

1972

Other Studies

1 other study(ies) available for fluocinolone acetonide and Acute Disease

ArticleYear
Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect?
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:3 Pt 1

    Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Fluocinolone Acetonide; Forced Expiratory Volume; Genes, MHC Class II; Glucocorticoids; Humans; Microcirculation; Peak Expiratory Flow Rate; Receptors, Glucocorticoid; Transcription, Genetic; Vasoconstrictor Agents

1998